My Quote Request
No products added yet
6505-01-368-6577
20 Products
NDC49230-0188-20
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
NDC49230-0188-20
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 3.500 MILLIGRAMS CALCIUM ION ACTIVE INGREDIENT AND 132.000 MILLIGRAMS SODIUM ION ACTIVE INGREDIENT AND 102.000 MILLIGRAMS CHLORIDE ION ACTIVE INGREDIENT AND 1.500 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 LITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND LACTATE ION 35.000 MILLEQUIVALENTS ACTIVE INGREDIENT
Related Searches:
DELFLEX
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
DELFLEX
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 3.500 MILLIGRAMS CALCIUM ION ACTIVE INGREDIENT AND 132.000 MILLIGRAMS SODIUM ION ACTIVE INGREDIENT AND 102.000 MILLIGRAMS CHLORIDE ION ACTIVE INGREDIENT AND 1.500 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 LITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND LACTATE ION 35.000 MILLEQUIVALENTS ACTIVE INGREDIENT
Related Searches:
3578
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
357886
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00006-0106-86
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
NDC00006-0106-86
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC66685-0703-03
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
NDC66685-0703-03
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PRINIVIL
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PRINIVIL TABLETS
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
PRINIVIL TABLETS
LISINOPRIL TABLETS,USP
NSN, MFG P/N
6505013686604
NSN
6505-01-368-6604
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 10MG 5000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0954-130
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
0954-130
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 25ML VIAL 50S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
CONRAY
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
CONRAY
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 25ML VIAL 50S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
CONRAY 400
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
CONRAY 400
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 25ML VIAL 50S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
F92G359
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
F92G359
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013688381
NSN
6505-01-368-8381
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 25ML VIAL 50S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
LORABID
LORACARBEF CAPSULES
NSN, MFG P/N
6505013689149
NSN
6505-01-368-9149
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF CAPSULES 200MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG
Related Searches:
NDC00247-0261-30
LORACARBEF CAPSULES
NSN, MFG P/N
6505013689149
NSN
6505-01-368-9149
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF CAPSULES 200MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG
Related Searches:
NDC00256-0133-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
NDC00256-0133-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
MFG
FLEMING AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 1.250 MILLIGRAMS METHSCOPOLAMINE NITRATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE METHSCOPOLAMINE NITRATE & PHENYLE TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59196-0003-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
NDC59196-0003-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
MFG
WE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 1.250 MILLIGRAMS METHSCOPOLAMINE NITRATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE METHSCOPOLAMINE NITRATE & PHENYLE TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC64455-0013-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
NDC64455-0013-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013689152
NSN
6505-01-368-9152
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 1.250 MILLIGRAMS METHSCOPOLAMINE NITRATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE METHSCOPOLAMINE NITRATE & PHENYLE TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-1484-02
NITROGLYCERIN IN DEXTROSE INJECTION
NSN, MFG P/N
6505013690450
NSN
6505-01-369-0450
NDC00074-1484-02
NITROGLYCERIN IN DEXTROSE INJECTION
NSN, MFG P/N
6505013690450
NSN
6505-01-369-0450
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: IN 5% DEXTROSE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
2G3543
PENICILLIN G POTASSIUM INJECTION,USP
NSN, MFG P/N
6505013690451
NSN
6505-01-369-0451
2G3543
PENICILLIN G POTASSIUM INJECTION,USP
NSN, MFG P/N
6505013690451
NSN
6505-01-369-0451
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
PRIMARY CONTAINER CONTENT QUANTITY: 2000000.000 UNITS
PRIMARY CONTAINER TYPE: BAG
SPECIAL FEATURES: 50 ML. PENICILLIN G POTASSIUM; ISO-OSMOTIC IN DEXTROSE; FROZEN PIGGIBACK BAG
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00338-1023-41
PENICILLIN G POTASSIUM INJECTION,USP
NSN, MFG P/N
6505013690451
NSN
6505-01-369-0451
NDC00338-1023-41
PENICILLIN G POTASSIUM INJECTION,USP
NSN, MFG P/N
6505013690451
NSN
6505-01-369-0451
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
PRIMARY CONTAINER CONTENT QUANTITY: 2000000.000 UNITS
PRIMARY CONTAINER TYPE: BAG
SPECIAL FEATURES: 50 ML. PENICILLIN G POTASSIUM; ISO-OSMOTIC IN DEXTROSE; FROZEN PIGGIBACK BAG
TOTAL PRIMARY CONTAINER QUANTITY: 24
